OpenURL Connection Search

Select item for more details and to access through your institution.

Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor.
Published in:
Science Translational Medicine, 2014, v. 6, n. 243, p. 1, doi. 10.1126/scitranslmed.3008992
By:
- Pegu, Amarendra;
- Zhi-yong Yang;
- Boyington, Jeffrey C.;
- Lan Wu;
- Sung-Youl Ko;
- Schmidt, Stephen D.;
- McKee, Krisha;
- Wing-Pui Kong;
- Wei Shi;
- Xuejun Chen;
- Todd, John-Paul;
- Letvin, Norman L.;
- Jinghe Huang;
- Nason, Martha C.;
- Hoxie, James A.;
- Kwong, Peter D.;
- Connors, Mark;
- Rao, Srinivas S.;
- Mascola, John R.;
- Nabel, Gary J.
Publication type:
Article
Functional Genomics for Personalized Cancer Therapy.
Published in:
Science Translational Medicine, 2014, v. 6, n. 243, p. 1, doi. 10.1126/scitranslmed.3009586
By:
- Tyner, Jefrey W.
Publication type:
Article
Determinants of Breast Cancer Progression.
Published in:
Science Translational Medicine, 2014, v. 6, n. 243, p. 1, doi. 10.1126/scitranslmed.3009587
By:
- Li Ma
Publication type:
Article
Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease.
Published in:
Science Translational Medicine, 2014, v. 6, n. 243, p. 1, doi. 10.1126/scitranslmed.3008941
By:
- Nalle, Sam C.;
- Kwak, H. Aimee;
- Edelblum, Karen L.;
- Joseph, Nora E.;
- Singh, Gurminder;
- Khramtsova, Galina F.;
- Mortenson, Eric D.;
- Savage, Peter A.;
- Turner, Jerrold R.
Publication type:
Article
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.
Published in:
Science Translational Medicine, 2014, v. 6, n. 243, p. 1, doi. 10.1126/scitranslmed.3009093
By:
- Kleinberger, Gernot;
- Yoshinori Yamanishi;
- Suárez-Calvet, Marc;
- Czirr, Eva;
- Lohmann, Ebba;
- Cuyvers, Elise;
- Struyfs, Hanne;
- Pettkus, Nadine;
- Wenninger-Weinzierl, Andrea;
- Mazaheri, Fargol;
- Tahirovic, Sabina;
- Lleó, Alberto;
- Alcolea, Daniel;
- Fortea, Juan;
- Willem, Michael;
- Lammich, Sven;
- Molinuevo, José L.;
- Sánchez-Valle, Raquel;
- Antonell, Anna;
- Ramirez, Alfredo
Publication type:
Article
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production.
Published in:
Science Translational Medicine, 2014, v. 6, n. 243, p. 1, doi. 10.1126/scitranslmed.3008961
By:
- Gauvreau, Gail M.;
- Harris, Jeffrey M.;
- Boulet, Louis-Philippe;
- Scheerens, Heleen;
- Fitzgerald, J. Mark;
- Putnam, Wendy S.;
- Cockcroft, Donald W.;
- Davis, Beth E.;
- Leigh, Richard;
- Yanan Zheng;
- Dahlén, Barbro;
- Yehong Wang;
- Maciuca, Romeo;
- Mayers, Irvin;
- Charlene Liao, X.;
- Wu, Lawren C.;
- Matthews, John G.;
- O'Byrne, Paul M.
Publication type:
Article

Found: 6

Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor.

Functional Genomics for Personalized Cancer Therapy.

Determinants of Breast Cancer Progression.

Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease.

TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.

Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production.